Australia Fill-finish Pharmaceutical Contract Manufacturing Market Size & Outlook

The fill-finish pharmaceutical contract manufacturing market in Australia is expected to reach a projected revenue of US$ 536.4 million by 2030. A compound annual growth rate of 6% is expected of Australia fill-finish pharmaceutical contract manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$355.8
Forecast, 2030 (US$M)
$536.4
CAGR, 2024 - 2030
6%
Report Coverage
Australia

Australia fill-finish pharmaceutical contract manufacturing market, 2018-2030 (US$M)

Australia

Related Markets

Australia fill-finish pharmaceutical contract manufacturing market highlights

  • The Australia fill-finish pharmaceutical contract manufacturing market generated a revenue of USD 355.8 million in 2023 and is expected to reach USD 536.4 million by 2030.
  • The Australia market is expected to grow at a CAGR of 6% from 2024 to 2030.
  • In terms of segment, large molecules was the largest revenue generating molecule type in 2023.
  • Small molecules is the most lucrative molecule type segment registering the fastest growth during the forecast period.


Fill-finish pharmaceutical contract manufacturing market data book summary

Market revenue in 2023USD 355.8 million
Market revenue in 2030USD 536.4 million
Growth rate6% (CAGR from 2023 to 2030)
Largest segmentLarge molecules
Fastest growing segmentSmall molecules
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationLarge Molecules, Small molecules
Key market players worldwideBoehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International


Other key industry trends

  • In terms of revenue, Australia accounted for 3.8% of the global fill-finish pharmaceutical contract manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China fill-finish pharmaceutical contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,008.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Fill-finish Pharmaceutical Contract Manufacturing Market Companies

Name Profile # Employees HQ Website

Australia fill-finish pharmaceutical contract manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.


Large molecules was the largest segment with a revenue share of 67.09% in 2023. Horizon Databook has segmented the Australia fill-finish pharmaceutical contract manufacturing market based on large molecules, small molecules covering the revenue growth of each sub-segment from 2018 to 2030.


Australia has a highly advanced healthcare industry. The increasing awareness of the need for the early detection of lifestyle and chronic diseases is boosting the pharmaceutical industry in the country. The Australian government has undertaken various schemes to provide medicines at subsidized rates.

For instance, as per the Pharmaceutical Benefits Scheme (PBS), medicines are available for all eligible patients at a subsidized cost. The abovementioned factors are expected to improve & promote the demand for fill-finish pharmaceutical manufacturing in the country, thus, boosting the demand for contract manufacturing services. Some of the key players contributing to the country’s market growth are Patheon, Althea Group, Catalent, Inc., and Novartis.

Reasons to subscribe to Australia fill-finish pharmaceutical contract manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia fill-finish pharmaceutical contract manufacturing market databook

  • Our clientele includes a mix of fill-finish pharmaceutical contract manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Australia fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia fill-finish pharmaceutical contract manufacturing market size, by molecule type, 2018-2030 (US$M)

Australia Fill-finish Pharmaceutical Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

Australia fill-finish pharmaceutical contract manufacturing market size, by molecule type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more